Cargando…

Long-Term Outcomes of Complete Versus Incomplete Revascularization for Patients with Multivessel Coronary Artery Disease and Left Ventricular Systolic Dysfunction in Drug-Eluting Stent Era

We aimed to investigate that complete revascularization (CR) would be associated with a decreased mortality in patients with multivessel disease (MVD) and reduced left ventricular ejection fraction (LVEF). We enrolled a total of 263 patients with MVD and LVEF <50% who had undergone percutaneous c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sohn, Gwan Hyeop, Yang, Jeong Hoon, Choi, Seung-Hyuk, Song, Young Bin, Hahn, Joo-Yong, Choi, Jin-Ho, Gwon, Hyeon-Cheol, Lee, Sang Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234917/ https://www.ncbi.nlm.nih.gov/pubmed/25408581 http://dx.doi.org/10.3346/jkms.2014.29.11.1501

Ejemplares similares

Differential Clinical Outcomes Between Angiographic Complete Versus Incomplete Coronary Revascularization, According to the Presence of Chronic Kidney Disease in the Drug‐Eluting Stent Era
por: Kim, Jihoon, et al.
Publicado: (2018)

Drug-coated balloon-based versus drug-eluting stent-only revascularization in patients with diabetes and multivessel coronary artery disease
por: Her, Ae-Young, et al.
Publicado: (2023)

Clinical Implications of Early Exercise Treadmill Testing after Percutaneous Coronary Intervention in the Drug-eluting Stent Era
por: Cho, Sung Woo, et al.
Publicado: (2020)

The Impact of Renal Dysfunction on the Long Term Clinical Outcomes of Diabetic Patients Undergoing Percutaneous Coronary Intervention in the Drug-Eluting Stent Era
por: Choi, Ki Hong, et al.
Publicado: (2016)

Comparison of Exercise Performance and Clinical Outcome Between Functional Complete and Incomplete Revascularization
por: Kim, Jihoon, et al.
Publicado: (2020)

Clinical outcomes of biodegradable polymer biolimus-eluting BioMatrix stents versus durable polymer everolimus-eluting Xience stents
por: Lee, Da Hyon, et al.
Publicado: (2017)

Complete Versus Culprit-Only Revascularization for ST-Segment Elevation Myocardial Infarction and Multivessel Disease in the 2(nd) Generation Drug-Eluting Stent Era: Data from the INTERSTELLAR Registry
por: Kwon, Sung Woo, et al.
Publicado: (2018)

Differential clinical impact of chronic total occlusion revascularization based on left ventricular systolic function
por: Kook, Hyungdon, et al.
Publicado: (2020)

Clinical Insights to Complete and Incomplete Surgical Revascularization in Atrial Fibrillation and Multivessel Coronary Disease
por: Pasierski, Michal, et al.
Publicado: (2022)

Culprit-Lesion-Only Versus Multivessel Revascularization Using Drug-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: A Korean Acute Myocardial Infarction Registry-Based Analysis
por: Jo, Hyun Su, et al.
Publicado: (2011)

Use of intravascular ultrasound and long-term cardiac death or myocardial infarction in patients receiving current generation drug-eluting stents
por: Lee, Sang Yoon, et al.
Publicado: (2022)

Multivessel versus IRA-only PCI in patients with NSTEMI and severe left ventricular systolic dysfunction
por: Lee, Myunhee, et al.
Publicado: (2021)

Percutaneous Coronary Intervention versus Coronary Artery Bypass Grafting for Diabetics with Multivessel Coronary Artery Disease: The Korean Multicenter Revascularization Registry (KORR)
por: Gwon, Hyeon-Cheol, et al.
Publicado: (2005)

Safety and Efficacy of Biodegradable Polymer-biolimus-eluting Stents (BP-BES) Compared with Durable Polymer-everolimus-eluting Stents (DP-EES) in Patients Undergoing Complex Percutaneous Coronary Intervention
por: Song, Pil Sang, et al.
Publicado: (2018)

The Predictors of Target Lesion Revascularization and Rate of In-Stent Restenosis in the Second-Generation Drug-Eluting Stent Era
por: Zheng, Chengbin, et al.
Publicado: (2019)

Incomplete revascularization in the drug eluting stent era permits meaningful long-term (12-78 months) outcomes in patients ≥ 75 years with acute coronary syndrome
por: Chen, Jie, et al.
Publicado: (2012)

First-Generation Versus Second-Generation Drug-Eluting Stents in Coronary Chronic Total Occlusions: Two-Year Results of a Multicenter Registry
por: Ahn, Jong-Hwa, et al.
Publicado: (2016)

Extensive Late-Acquired Incomplete Stent Apposition After Sirolimus-Eluting Stent Implantation
por: Choi, Hyun-Chul, et al.
Publicado: (2010)

Effects of Everolimus-Eluting Stents on the Left Ventricular Systolic and Diastolic Functions
por: Parsaee, Mohammad Sadegh, et al.
Publicado: (2015)

Angiotensin receptor blocker in patients with ST segment elevation myocardial infarction with preserved left ventricular systolic function: prospective cohort study
por: Yang, Jeong Hoon, et al.
Publicado: (2014)

Impact of Incomplete Percutaneous Revascularization in Patients With Multivessel Coronary Artery Disease: A Systematic Review and Meta‐Analysis
por: Nagaraja, Vinayak, et al.
Publicado: (2016)

Angiographic Complete versus Clinical Selective Incomplete Percutaneous Revascularization in Heart Failure Patients with Multivessel Coronary Disease
por: Chang, Chieh-Yu, et al.
Publicado: (2020)

Establishment of a Predictive Model for Poor Prognosis of Incomplete Revascularization in Patients with Coronary Heart Disease and Multivessel Disease
por: Lian, Huan, et al.
Publicado: (2022)

Drug-Eluting Stents in Multivessel Coronary Artery Disease: Cost Effectiveness and Clinical Outcomes
por: Panchal, Kanaiya, et al.
Publicado: (2012)

Comparison of Long‐Term Clinical Outcome Between Multivessel Percutaneous Coronary Intervention Versus Infarct‐Related Artery–Only Revascularization for Patients With ST‐Segment–Elevation Myocardial Infarction With Cardiogenic Shock
por: Lee, Joo Myung, et al.
Publicado: (2019)

Coronary Artery Bypass Grafting vs. Drug-Eluting Stent Implantation for Multivessel Disease in Patients with Chronic Kidney Disease
por: Kang, Se Hun, et al.
Publicado: (2017)

Optimal Revascularization Strategy in Non–ST‐Segment–Elevation Myocardial Infarction With Multivessel Coronary Artery Disease: Culprit‐Only Versus One‐Stage Versus Multistage Revascularization
por: Kim, Min Chul, et al.
Publicado: (2020)

Safety and Efficacy of Everolimus-Eluting Bioresorbable Vascular Scaffold Versus Second-Generation Drug-Eluting Stents in Real-World Practice
por: Lee, Joo Myung, et al.
Publicado: (2023)

Long-term Survival Benefit of Statin in Patients with Coronary Chronic Total Occlusion without Revascularization
por: Kim, Bum Sung, et al.
Publicado: (2018)

Revascularization and survival in multivessel coronary artery disease in ischemia
por: Maron, David J., et al.
Publicado: (2022)

Successful Retrieval of Intravascular Stent Remnants With a Combination of Rotational Atherectomy and a Gooseneck Snare
por: Kim, Jung Hyuk, et al.
Publicado: (2012)

Identification of independent risk factors for restenosis following bare-metal stent implantation: Role of bare-metal stents in the era of drug-eluting stents
por: PARK, CHANG-BUM, et al.
Publicado: (2013)

Understanding the role of coronary artery revascularization in patients with left ventricular dysfunction and multivessel disease
por: Acerbo, Vincenzo, et al.
Publicado: (2023)

Outcomes of Different Reperfusion Strategies of Multivessel Disease Undergoing Newer-Generation Drug-Eluting Stent Implantation in Patients with Non-ST-Elevation Myocardial Infarction and Chronic Kidney Disease
por: Kim, Yong Hoon, et al.
Publicado: (2021)

Effect of revascularization strategy in patients with acute myocardial infarction and renal insufficiency with multivessel disease
por: Park, Hyukjin, et al.
Publicado: (2015)

Application of rotational atherectomy in the drug-eluting stent era
por: Chen, Chun-Chi, et al.
Publicado: (2013)

Incremental age-related one-year MACCE after acute myocardial infarction in the drug-eluting stent era (from KAMIR-NIH registry)
por: Kim, Dae-Won, et al.
Publicado: (2018)

Efficacy and safety of drug-eluting stenting compared with bypass grafting in diabetic patients with multivessel and/or left main coronary artery disease
por: Xin, Xiaojun, et al.
Publicado: (2019)

State-of-the-Art Stent Technology to Minimize the Risk of Stent Thrombosis and In-Stent Restenosis: Abluminal-Coated Biodegradable Polymer Drug-Eluting Stent
por: Kang, Dong Oh, et al.
Publicado: (2022)

Does multivessel revascularization fit all patients with STEMI and multivessel coronary artery disease? A systematic review and meta-analysis
por: Hu, Meng-Jin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bekoh9a1slcsf9mvqseavb7d1g